Prevalence and Association of Anxiety and Sleep Disturbances Among Medical Students.

April 29, 2025 updated by: Yuvraj Kaushal, Government Medical College, Patiala

The Prevalence and Association of Anxiety and Sleep Disturbances Among Medical Students: A Cross-sectional Study

Observational, Cross-sectional study

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It was a cross-sectional study conducted in December 2024 with the consent of 200 undergraduate medical students of a tertiary care hospital affiliated medical college, who qualified as per the inclusion criteria.

Inclusion criteria:

All the students of MBBS Phase-II.

Exclusion criteria:

Students with prior diagnosed Sleep disorders Students with prior diagnosed co-morbidities Students unable/unwilling to answer the question.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • India
    • Punjab
      • Patiala, Punjab, India, 147001
        • Yuvraj Kaushal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Students of MBBS

Description

Inclusion criteria:

- All the students of MBBS Phase-II.

Exclusion criteria:

  • Students with prior diagnosed Sleep disorders
  • Students with prior diagnosed co-morbidities
  • Students unable/unwilling to answer the question.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Phase-2 MBBS Students
The group included in Phase-2 MBBS Students i.e. 2nd year students in med school
Other: Survey using a questionnaire.
Survey was conducted to collect their responses to PSQI and BAI questionnaires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Sleep Disturbances
Time Frame: 1 month
The Pittsburgh Sleep Quality Index (PSQI) has been used to assess the pattern and the quality of sleep.[8] This questionnaire assesses sleep quality over a 1-month time interval based on self-report by the participant. PSQI differentiates 'Poor' from 'Good' sleep by measuring Seven Domains: Subjective Sleep Quality, Latency, Sleep Duration, Sleep Efficiency, Disturbances, Medication, and Daytime Dysfunction over the last month. The measure consists of 19 individual items, creating 7 components that produce one global score and take 5-10 minutes to complete.
1 month
Assessment of Anxiety
Time Frame: 1 month
To assess Anxiety, the Beck Anxiety Inventory (BAI)[9] has been used. This scale is a self-report measure of anxiety in children and adults, which asks the subject to rate 21 items on a scale of 0-3. The questions used in this measure ask the subject about common symptoms of anxiety that the subject had had during the past week. It is designed for individuals aged 17 and above and takes 5-10 minutes to complete. The total score is calculated by the standard mean of the responses to the 21 items. A score of 0-21 = low anxiety. A score of 22-35 = moderate anxiety. A Score of 36 and above signifies potentially concerning levels of anxiety.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Government Medical College, Patiala

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2024

Primary Completion (Actual)

December 30, 2024

Study Completion (Actual)

December 30, 2024

Study Registration Dates

First Submitted

April 21, 2025

First Submitted That Met QC Criteria

April 29, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Trg.9(310)2024/13198-201

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Participant Confidentiality

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Survey using a questionnaire.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe